LD-2 disclosure · 3rd Quarter - Report
EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION)
Client
- Name
- EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION)
- Description
- Manufacturing and distribution of biodefense vaccines & therapeutics & cancer drug R&D
- Location
- Maryland · United States of America
Registrant
- Description
- Business Consulting
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
3 issuesDefense
Anthrax vaccine, antitoxin and immunoglobulin, and CBRN medical countermeasure research, acquisition, legislation, funding, appropriations and oversight.
Lobbyistsmr DONALD DALRYMPLE
Covered position (mr DONALD DALRYMPLE): Principal
TargetedSENATE · HOUSE OF REPRESENTATIVES · White House Office · Defense, Dept of (DOD) · Army, Dept of (Other) · Health & Human Services, Dept of (HHS) · Ballistic Missile Defense Organization · Centers For Disease Control & Prevention (CDC) · Food & Drug Administration (FDA) · Natl Institutes of Health (NIH) · Homeland Security, Dept of (DHS) · Defense Threat Reduction Agency (DTRA)
Homeland Security
Anthrax vaccine, anthrax antitoxin, anthrax immune globulin and CBRN Medical Countermeasures research, acquisition and funding, legislation, appropriations, and oversight and medical countermeasure first responder preparedness.
Lobbyistsmr DONALD DALRYMPLE
Covered position (mr DONALD DALRYMPLE): Principal
TargetedSENATE · HOUSE OF REPRESENTATIVES · White House Office · Defense, Dept of (DOD) · Army, Dept of (Other) · Health & Human Services, Dept of (HHS) · Ballistic Missile Defense Organization · Centers For Disease Control & Prevention (CDC) · Food & Drug Administration (FDA) · Natl Institutes of Health (NIH) · Homeland Security, Dept of (DHS) · Defense Threat Reduction Agency (DTRA)